releases: https://obernolte.house.gov/media/press-releases/rep-obernolte-addresses-local-drug-shortages-energy-and-commerce-committee
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://obernolte.house.gov/media/press-releases/rep-obernolte-addresses-local-drug-shortages-energy-and-commerce-committee | Rep. Obernolte addresses local drug shortages at Energy and Commerce Committee hearing | 2023-09-20 | 2023 | 2023-09 | Republican | House | CA | Jay Obernolte | O000019 | obernolte.house.gov | obernolte | https://obernolte.house.gov/media/press-releases | scraper | U.S. Congressman Jay Obernolte (R-Hesperia) questioned top leaders in the drug supply chain at a hearing of the U.S. House of Representatives Committee on Energy and Commerce’s Health Subcommittee to address the underlying economic drivers of generic drug shortages. The hearing follows Rep. Obernolte’s recent meeting with his Health Advisory Committee where High Desert and Inland Empire health care providers indicated drug shortages were a top concern for hospitals. “At the August meeting of my Health Advisory Committee, representatives from every hospital across California’s 23rd District indicated that shortages of certain drugs were one of their primary concerns in ensuring quality care for patients in the High Desert and Inland Empire,” said Rep. Obernolte. “Our recent hearing into potential changes to government rules that would enable stakeholders to address shortages more quickly is an important first step in addressing this issue.” WATCH REP. OBERNOLTE’S HEARING Q&A HERE | 1 | 2026-03-30T01:40:41Z | 2026-04-08T00:37:48Z |